Copertina

Comparison of novel intrinsic versus conventional antitachycardia pacing for ventricular tachycardia among implantable cardioverter‐defibrillator recipients

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Satoshi Yanagisawa, Yasuya Inden, Yuki Sato, Ryo Watanabe, Takayuki Goto, Shun Kondo, Masaya Tachi, Tomoya Iwawaki, Ryota Yamauchi, Kei Hiramatsu, Masafumi Shimojo, Yukiomi Tsuji, Rei Shibata, Toyoaki Murohara
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2024
Soggetti:	Journal of Cardiovascular Electrophysiology
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

A Novel Liver Fibrosis Marker FIB‐5 Index Predicted Response to Cardiac Resynchronization Therapy and Prognostic Outcomes in Patients With Heart Failure
di: Tomoya Iwawaki, et al.
Pubblicazione: (2024)

An abrupt loss of capture during permanent His‐bundle pacing: Assessment of mechanism underlying late capture threshold rise
di: Hiroyuki Kato, et al.
Pubblicazione: (2024)

Feasibility of left bundle branch area pacing with left axillary pacemaker implantation in a young female patient with heart failure
di: Hiroyuki Kato, et al.
Pubblicazione: (2025)

Editorial to “Pre‐procedural imaging guiding ventricular tachycardia ablation in structural heart disease”
di: Yoshiaki Mizutani, et al.
Pubblicazione: (2025)

Early Left Ventricular Reverse Remodeling After Catheter Ablation of Atrial Fibrillation is Associated With Lower Recurrence Rates and Improved Prognosis in Patients With Left Ventricular Systolic Dysfunction
di: Hiroyuki Miyazawa, et al.
Pubblicazione: (2025)

Fig. 1. Leucosia rubripalma Galil, 8 in Some Subtidal Crabs (Crustacea, Decapoda, Brachyura) from Suruga Bay, Pacific Coast of Central Japan
di: Mizutani, Yoshiaki, et al.
Pubblicazione: (2025)

Fig. 5 in Some Subtidal Crabs (Crustacea, Decapoda, Brachyura) from Suruga Bay, Pacific Coast of Central Japan
di: Mizutani, Yoshiaki, et al.
Pubblicazione: (2025)

Selective Left Bundle Branch Capture Using the Uninterrupted Monitoring Technique: Mid‐Term Performance and Safety Profile
di: Hiroyuki Kato, et al.
Pubblicazione: (2025)

Editorial to “Novel mapping techniques for ablation of non‐pulmonary vein foci using complex signal identification”
di: Yoshiaki Mizutani, et al.
Pubblicazione: (2025)

Synthesized V7 QRS Amplitude and Oversensing Episodes in Patients With Subcutaneous Implantable Cardioverter‐Defibrillators
di: Takashi Okajima, et al.
Pubblicazione: (2024)

Prognostic value of noninvasive programmed stimulation in primary prevention implantable cardioverter‐defibrillator recipients
di: Piotr Futyma, et al.
Pubblicazione: (2024)

Clinical Superiority of Active Fixation Quadripolar Leads in Cardiac Resynchronization Therapy
di: Kazuyuki Yamanaka, et al.
Pubblicazione: (2026)

Evaluation of microembolic signals on carotid ultrasound during pulmonary vein isolation with high‐power short‐duration and cryoballoon ablations: When and where do bubble and solid emboli arise?
di: Yoshiaki Mizutani, et al.
Pubblicazione: (2024)

Quality of life and acceptance of the extravascular implantable cardioverter‐defibrillator
di: Razan Dankar, et al.
Pubblicazione: (2024)

How to indicate implantable cardioverter‐defibrillator in the aging population
di: Risako Orita, et al.
Pubblicazione: (2025)

Long‐term safety and efficacy of subcutaneous implantable cardioverter‐defibrillator compared with transvenous implantable cardioverter‐defibrillator in propensity score‐matched patients from Japan
di: Yuki Konno, et al.
Pubblicazione: (2025)

Experiences of adults living with an implantable cardioverter defibrillator for cardiovascular disease
Pubblicazione: (2024)

Mid‐term outcomes of delivery catheter‐based and stylet‐based right ventricular septal pacing: Follow‐up results from a multicenter, prospective, randomized study
di: Naoki Tsurumi, et al.
Pubblicazione: (2024)

Disparities in the implantation of secondary prevention implantable cardioverter defibrillator in the United States
di: Ahmed Maraey, et al.
Pubblicazione: (2024)

RE: Clinical implication of detected tachyarrhythmias in patients with implantable cardioverter defibrillators
di: Amole Ojo, et al.
Pubblicazione: (2024)

Prognostic comparison between implantable cardioverter‐defibrillator and amiodarone in cancer patients
di: Hirota Kida, et al.
Pubblicazione: (2025)

A spontaneous or pacing‐induced transition from slow‐fast atrioventricular nodal reentrant tachycardia to fast‐slow type using a superior slow pathway
di: Hiroyuki Miyazawa, et al.
Pubblicazione: (2024)

The impact of supraventricular arrhythmias on the outcomes of guideline‐compliant implantable cardioverter defibrillator programming
di: Padoemwut Teerawongsakul, et al.
Pubblicazione: (2024)

Patient characteristics, predictors and outcome of pacemaker patients upgraded to an implantable cardioverter defibrillator
di: Samuel H. Baldinger, et al.
Pubblicazione: (2024)

The clinical and economic impact of extended battery longevity of the extravascular implantable cardioverter defibrillator
di: Razan Dankar, et al.
Pubblicazione: (2024)

Comment on: Benefit of primary and secondary prophylactic implantable cardioverter defibrillator in elderly patients
di: Vadim Zakiev, et al.
Pubblicazione: (2024)

Aligning goals with care: Advance directives in older adults with implantable cardioverter‐defibrillators
di: Warren D. Backman, et al.
Pubblicazione: (2024)

Left Atrial Remodeling After Pacemaker Implantation Predicts Incident Atrial Fibrillation: Comparison of Leadless and Transvenous Devices
di: Naoya Inoue, et al.
Pubblicazione: (2026)

Survival benefit of primary prevention implantable cardioverter‐defibrillator/cardiac resynchronization therapy with a defibrillator: Analysis of the Japan cardiac device treatment registry and Japanese cardiac registry of heart failure in cardiology
di: Hisashi Yokoshiki, et al.
Pubblicazione: (2025)

Management of patients following implantable cardioverter‐defibrillator therapy—The importance of a multifaceted approach
di: Karshana Selvarajah, et al.
Pubblicazione: (2024)

Is it safe to give birth with an activated implantable cardioverter–defibrillator: A multicentre observational study
di: Willeke van der Stuijt, et al.
Pubblicazione: (2024)

Risk of supranormal left ventricular ejection fraction in patients with aortic stenosis
di: Naoya Inoue, et al.
Pubblicazione: (2024)

Subcutaneous air entrapment after subcutaneous implantable cardioverter defibrillator implantation evaluated by computed tomography
di: Yuka Taguchi, et al.
Pubblicazione: (2024)

Prophylactic implantation of cardioverter‐defibrillator in patients with advanced light‐chain amyloidosis—A pilot study
di: Hui‐Qiang Wei, et al.
Pubblicazione: (2025)

The clinical and economic impact of extended battery longevity of a substernal extravascular implantable cardioverter defibrillator
di: Stuart Mealing, et al.
Pubblicazione: (2024)

An extremely wide QRS complex tachycardia induced by anamorelin
di: Kazuki Shimojo, et al.
Pubblicazione: (2024)

Implantable cardioverter‐defibrillator lead failure and revision following transcutaneous bicaval valve (TricValve®) implantation
di: Allan Plant, et al.
Pubblicazione: (2024)

How to demonstrate the clinical implication of prophylactic implantable cardioverter–defibrillator in patients with advanced light chain amyloidosis
di: Naoya Kataoka, et al.
Pubblicazione: (2025)

Chronic phase subcutaneous implantable cardioverter defibrillator lead dislodgement in a patient with arrhythmogenic right ventricular cardiomyopathy
di: Ryuki Chatani, et al.
Pubblicazione: (2024)

Lead and generator dysfunction in children and adolescents with epicardial pacemaker and implantable cardioverter defibrillator systems: The challenge of early recognition
di: Florian Winkler, et al.
Pubblicazione: (2024)